Fig. 2From: Investigating the risk of metabolic and cardiovascular comorbidities among patients with parathyroid cancer: a nationwide representative cohort study in TaiwanMultivariable-adjusted hazard ratios with 95% confidence interval of all cause and cancer-specific mortality, hypertension, diabetes, hyperlipidemia, atrial fibrillation, coronary artery disease, and heart failure among parathyroid cancer patients compared with matching populationBack to article page